David Pendarvis - Jun 3, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Jun 3, 2022
Transactions value $
-$323,585
Form type
4
Date filed
6/7/2022, 08:35 AM
Previous filing
May 4, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$324K -1.55K -1.41% $209.44 108K Jun 3, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes 62.7151 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan.